KREJCOVA, Ludmila, Ivo FABRIK, David HYNEK, Soňa KRIZKOVA, Jaromír GUMULEC, Marketa RYVOLOVA, Vojtech ADAM, Petr BABULA, Libuše TRNKOVÁ, Marie STIBOROVA, Jaromir HUBALEK, Michal MASAŘÍK, Hana BINKOVÁ, Tomáš ECKSCHLAGER a René KIZEK. Metallothionein Electrochemically Determined using Brdicka Reaction as a Promising Blood Marker of Head and Neck Malignant Tumours. International Journal of Electrochemical Science. 2012, roč. 7, č. 3, s. 1767 - 1784. ISSN 1452-3981.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Metallothionein Electrochemically Determined using Brdicka Reaction as a Promising Blood Marker of Head and Neck Malignant Tumours
Autoři KREJCOVA, Ludmila (203 Česká republika, garant), Ivo FABRIK (203 Česká republika), David HYNEK (203 Česká republika), Soňa KRIZKOVA (203 Česká republika), Jaromír GUMULEC (203 Česká republika, domácí), Marketa RYVOLOVA (203 Česká republika), Vojtech ADAM (203 Česká republika), Petr BABULA (203 Česká republika), Libuše TRNKOVÁ (203 Česká republika, domácí), Marie STIBOROVA (203 Česká republika), Jaromir HUBALEK (203 Česká republika), Michal MASAŘÍK (203 Česká republika, domácí), Hana BINKOVÁ (203 Česká republika, domácí), Tomáš ECKSCHLAGER (203 Česká republika) a René KIZEK (203 Česká republika).
Vydání International Journal of Electrochemical Science, 2012, 1452-3981.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10405 Electrochemistry
Stát vydavatele Srbsko
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.729 v roce 2011
Kód RIV RIV/00216224:14110/12:00059527
Organizační jednotka Lékařská fakulta
UT WoS 000302730300003
Klíčová slova anglicky electrochemical detection; head and neck cancer; voltammetry; catalytic signal; metallothionein; marker
Příznaky Mezinárodní význam
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 26. 2. 2013 01:43.
Anotace
There are more than half of million patients who fall ill with head and neck carcinoma per year, which 6 % of annually newly diagnosed malignant diseases in the world. Group of head and neck tumours includes tumours occurring in the upper respiratory tract and upper digestive tract. They include tumours occurring in the area of oral cavity, tumours of hard and soft palate, gingivae and tongue. However, suitable markers in the case of head and neck carcinoma have not been satisfactory identified. Metallothioneins as a group of proteins with unknown but important role in development of a tumour can be assumed as a potential marker. Therefore, electrochemical monitoring of metallothionein levels in patients suffering from primary malignant tumour in head and neck area and examination of a suitability of electrochemical detection as a technique to be used in clinical practise are the most important aims of this study. Differential pulse voltammetry Brdicka reaction was optimized (time of accumulation 240 s, dilution of a sample 100 times and sample injection 10 microl) and used for analysis off blood obtained from 145 patients with newly diagnosed malignant tumour disease in the head and neck area. As a control, fifty eight blood samples were used. The obtained data enabled us to suggest reference MT level in blood of healthy human within the interval from 0.2 to 0.8 microM. In the tumour blood samples, the most extend group was represented by patients suffering from oropharyngeal cancer (n = 69, 47.5 %), laryngeal cancer (n = 36, 24.8 %), hypopharyngeal cancer (n = 14, 9.6 %), oral cavity cancer (n = 18, 12.4 %) and rarely occurring nasal cavity and paranasal sinus cancer (n = 4, 2.7 %) and parotid carcinoma (n = 4, 2.7%). Age median of the studied group was 60 years. Determined MT levels in blood of patients varied from 1.08 to 6.39 microM, whereas average values differed in the accordance with tumour localization. Differences between individual localizations are discussed. In conclusion, MT levels are closely associated with the rate of tumour differentiation, stage of tumour disease and tumour cell characteristics. Our study demonstrates not only changes in blood MT levels in patients suffering from malignant tumour disease in head and neck area, but also suitability of electrochemical techniques for blood analysis.
VytisknoutZobrazeno: 1. 9. 2024 00:41